A blockade of CD44 can interfere with haematopoietic and leukemic stem cell homing, the latter being considered as a therapeutic option in haematological malignancies. We here aimed to explore the molecular mechanism underlying the therapeutic efficacy of anti-CD44. 
Two recent reports describe that CD44 also accounts for leukaemia cell homing, some haematological malignancies revealing high CD44 expression particularly on the subpopulation of cancer initiating cells [8] . The acute myeloid leukaemia stem cell requires CD44 for the transport to the stem cell-supportive microenvironmental niche and anti-CD44 alters the fate of acute myeloid leukaemia stem cells by inducing differentiation [18] . In a mouse model of chronic myeloid leukaemia, BCR-ABL1-transduced progenitors from CD44-mutant donors were defective in bone marrow homing, which resulted in decreased engraftment and impaired CML-like disease induction. These studies provided additional evidence for a higher degree of CD44 dependence of leukemic than of haematopoietic stem cells [19] . The [20, 21] .
findings in both studies suggest that anti-CD44 promoted death of leukaemia-initiating cells, which possibly could be translated into a therapeutic strategy to eliminate quiescent leukemic stem cells (LSCs) by a blockade of CD44. However, because HSCs and LSCs are CD44 dependent, it would be desirable to know the pathway of anti-CD44-induced apoptosis and whether differences between HSCs and LSCs can be elaborated, where death could be a consequence of a deficit in survival signals from the haematopoietic niche or CD44 occupancy could actively initiate signals that promote apoptosis, where both the receptor-mediated and mitochondrial pathway have been assigned to CD44
During haematopoiesis as well as lymphocyte activation, CD44 has become assigned with promoting proliferation [22, 23] , cytokine secretion [24] , apoptosis protection as well as induction [8, 9] . CD44-induced apoptosis protection proceeds via activation of anti-apoptotic molecules [25, 26] . CD44-induced apoptosis obviously can proceed via different pathways [27] . CD44-initiated apoptosis has been described to be accompanied by up-regulation of apoptosis receptors [28, 29] or by HA binding in activated T cells, which has been CD95 and caspase independent [30] or by CD40 and CD44v7 cross-linking, which also is CD95 independent, but proceeds through caspase-3 and caspase-9 activation [31] suggestive of the involvement of the mitochondrial apoptosis pathway. In haematological malignancies, too, CD44 ligation can induce cell cycle arrest [32, 33] , differentiation and apoptosis [34] , which in erythroid leukaemia cells has been observed to be caspase independent, but accompanied by mitochondrial membrane destabilization and release of apoptosis-inducing factor, but not of cytochrome c [35] .
We [36] , which we recently could confirm [37] for the subpopulation of common lymphoid progenitor 2 cells (CLP2) [38] . Thus [39] and anti-CD49d (PS/2) [40] were purified by affinity chromatography. JO2 (hamster antimouse CD95) [41] was a kind gift from S. 
have been particularly interested in the role of CD44 in progenitor T-cell homing and maturation. CD44 is known as a thymus homing receptor for T progenitor cells

we asked, whether leukemic T-cell growth in vivo also requires CD44 and whether antibody occupancy of CD44 hampers settlement or actively promotes apoptosis. Using the EL4 thymoma line we demonstrate that CD44 contributes to T lymphoma homing and that a blockade of CD44 drives thymoma cells into apoptosis. Unravelling the molecular pathway of CD44-induced apoptosis in T lymphoma revealed a new pathway, initiated via activation of CD44-associated phosphatase 2A (PP2A), which inhibits ERK1/2 phosphorylation leading to mitochondrial membrane depolarization and caspase-9 activation.
Material and methods
Mice and tumours lines
Nagata (Kyoto University, Japan). Unlabelled, biotinylated or dye-labelled anti-CD44v6, -CD95, -CD95L, -(p)c-jun, -NFB, -TNFRI, -TNFRII, -TRAIL, -(p)ERK1,2, -pTyr, -pThr, -caspase-3, -caspase-9, -PI3K, -(p)Akt, -Ras, -Bcl-xL, -(p)BAD, -BAX, -(p)PP1, -
Raf-GST fusion protein and pull-down assay
Escherichia coli were transformed with a GST-Raf (AA1-149 of cRaf1) cDNA [42] Fig. 1G and H) .
The data are in line with several reports demonstrating that anti-CD44 interferes with thymoma growth, but concomitantly severely hampers the reconstitution process [21, 24] 
Anti-CD44 promotes thymoma cell apoptosis
To control for this hypothesis and to evaluate the underlying mechanism(s), EL4 and EL4v6 cells were cultured in the presence of 10 g/ml anti-CD44. After 16 hrs of culture in the presence of IM7 the percentage of apoptotic EL4/EL4v6 cells was measured by annexinV-FITC/PI staining. In the presence of soluble anti-panCD44 the apoptosis rate was increased after 6 hrs from ~2% to ~25% and after o/n culture from ~10% to ~30% (Fig. 2A). Similar effects were observed with YC18 cells, a BALB/cderived lymphoma (data not shown). In order to check for the specificity of apoptosis induction through CD44, we used HA and for EL4v6 cells anti-CD44v6. HA and anti-CD44v6 induced apoptosis in EL4 and EL4v6 cells comparably to anti-panCD44. Instead, the percentage of apoptotic cells was not increased in cultures containing an anti-MHC antibody or anti-CD49d, CD49d being expressed at a high level on EL4 cells (Fig. 2B). The increase in apoptotic cells obviously is not a consequence of activation induced cell death, as the distribution of cells in G1, S and G2 or M-phase did not vary significantly depending on the culture condition (Fig. 2C).
Fig. 1 The impact of anti-CD44 on thymoma growth in vivo: (A-E) C57BL6 mice received an i.v. (A) or s.c. (B, C) injection of 10 4 EL4 cells or (C, D)
were 
Anti-CD44 induces ERK inhibition through PP2A
To unravel the molecular pathway initiated downstream of CD44 engagement, we checked for early activation signalling events which might be involved. EL4 cells stimulated with IM7 for up to 2 hrs did not reveal any change in the phosphotyrosine profile (Fig. 5A ), PI3K activation (data not shown) and Akt phosphorylation (Fig. 5B) (Fig. 5D) .
These results suggesting that CD44 engagement leads to ERK inhibition through the activation of PP1 or PP2A, we controlled for the potential contribution of PP1 or PP2A. We did not observe PP1 phosphorylation concomitantly with ERK1/2 dephosphorylation (Fig. 5E) (Fig. 5F ). The association of PP2A is accompanied by PP2A activation as revealed by blotting the PP2A immunoprecipitates with anti-pThr (Fig. 5G) and evaluating phosphatase activity of PP2A immunoprecipitates after CD44 ligation (Fig. 5H) .
Having demonstrated PP2A activation upon association with CD44, we wanted to identify the mechanism responsible for PP2A activation, expecting due to CD44 association-dependent activation of PP2A that the upstream activator possibly may also be associated with CD44. MALDI-TOF analysis of proteins co-immunoprecipitating
Fig. 4 CD44 ligation induces apoptosis via the mitochondrial pathway: (A and B) EL4 and EL4v6 cells were cultured o/n in the presence of rIgG, IM7 or anti-CD44v6. Cultures contained in addition DMSO (control) or 2 M caspase-3 or caspase-9 inhibitor. Apoptosis was measured by annexinV-FITC/PI staining. (A) A representative example and (B) mean values Ϯ S.D. of triplicates are shown. Significant differences in the percentage of apoptotic cells in the presence of caspase inhibitors are indicated by *. (C) WB of caspase-3 and caspase-9 cleavage in lysates of EL4 cells cultured o/n in the presence of rIgG or IM7 or in the presence of a caspase-9 inhibitor. The mean values Ϯ S.D. of the ratio of caspase-3 : actin and cleaved : uncleaved caspase-9 are shown. Significant differences by IM7 or a caspase-9 inhibitor are indicated by an asterisk. Caspase-3 and capase-9 cleavage is enhanced in IM7 treated cells and caspase-9 cleavage is reduced in the presence of the caspase-9 inhibitor. (D) EL4 cells were stained with the mitochondrial dye DilC1 and incubated with 10 g/ml IM7 for 12 hrs. DilC1 staining was evaluated by flow cytometry. (E) EL4 cells were incubated with 10 g/ml IM7 for 12 hrs. Mitochondria were separated from the cytosol. Lysates were separated by SDS-PAGE, proteins were transferred to a nitrocellulose membrane and blotted with anti-cytochrome c. The mean values Ϯ S.D. of the ratio of cytochrome c in the cytosol : mitochondria is shown. Significant differences by IM7 or anti-CD44v6 are indicated by an asterisk. (D and E) Mitochondria integrity is strongly affected after 12 hrs of culture in the presence of IM7.
with CD44 revealed the presence of CK2, a constitutively active ser/thr kinase, which has a wide range of substrates including PP2A, which becomes threonine phosphorylated [44] . We confirmed a constitutive, though weak association between CK2 and CD44 by WB, which was increased after CD44 engagement (Fig. 6A) (Fig. 6C) and in a reduction of the basal level of pERK1/2 (Fig. 6D) . Instead, the CK2 inhibitor strongly interfered with spontaneous and IM7-promoted apoptosis (Fig. 6E) 
Fig. 5 CD44 ligation induces PP2A activation and ERK1/2 dephosphorylation: (A) EL4 cells were cultured for 30 min. in the presence of IM7. Cells were lysed and proteins were separated by SDS-PAGE, transferred to a nitrocellulose membrane and probed with anti-phosphotyrosine. (B and C) EL4 and EL4v6 cells were cultured for 15-60 min. in the presence of IM7. After lysis, SDS-PAGE and transfer, membranes were incubated with (B) anti-Akt and anti-pAkt and (C) anti-ERK1/2 and anti-pERK1/2. The mean values Ϯ S.D. of the ratio of pAkt : Akt and pERK1/2 : ERK1/2 are shown. Significant differences by IM7 are indicated by an asterisk. Tyrosine and Akt phosphorylation remained unaltered. ERK1/2 phosphorylation of EL4 and EL4v6 cells cultured in the presence of IM7 becomes strikingly reduced. (D) EL4 cells were cultured in the presence of rIgG or IM7 and increasing amounts of OA. Cells were lysed, lysates were separated by SDS-PAGE, transferred and blotted with anti-ERK1/2 and anti-pERK1/2. The mean values Ϯ S.D. of the ratio of pERK1/2 : ERK1/2 are shown. Significant differences by OA are indicated by an asterisk. In the presence of the phosphatase inhibitor, the IM7-induced reduction of ERK1/2 phosphorylation was prevented. (E) EL4 cells were cultured in the presence of rIgG or IM7. Cells were lysed, lysates were separated by SDS-PAGE, transferred and blotted with anti-pPP1, anti-ERK1/2 and anti-pERK1/2. The mean values Ϯ S.D. of the ratio of pPP1 : ERK1/2 and for comparison of pERK1/2 : ERK1/2 are shown. Significant differences by IM7 are indicated by an asterisk. PP1 did not become phosphorylated concomitantly with ERK1/2 dephosphorylation. (F) EL4 cells were cultured in the presence of IM7. Cells were lysed and immunoprecipitated with IM7 or anti-PP2A. Precipitates were separated by SDS-PAGE, transferred and blotted with IM7, anti-PP2A and anti-PP1. The mean values Ϯ S.D. of the ratio
ERK1/2 inhibition promotes apoptosis and caspase-9 cleavage
Our data so far suggest that PP2A activation-induced apoptosis proceeds through ERK1/2 inhibition. PP2A also is known to affect the PI3K/Akt pathway, that has already been excluded (Fig. 5B) (Fig. 7A) . in the presence of a MEK1,2 inhibitor (Fig. 7B) . In fact, when EL4 and EL4v6 cells were cultured in the presence of a MEK1,2 inhibitor, apoptosis became increased (Fig. 7C) , mitochondrial membrane depolarization was strengthened, as shown by the higher percentage of cells displaying reduced DilC1 staining (Fig. 7D) , and caspase-9 cleavage was pronounced (Fig. 7E) . Concomitantly, Bcl-2 expression and BAD phosphorylated was reduced and BAX expression was up-regulated. The same findings accounted for IM7-treated EL4 and EL4v6 cells (Fig. 7F) .
IM7-mediated PP2A activation, at least predominantly, inducing apoptosis through ERK1/2 inhibition, we evaluated whether an ERK1/2 inhibitor would induce apoptosis and whether apoptosis induction would proceed via caspase-9. EL4/EL4v6 cells show a high basic level of ERK activation, which was significantly inhibited
Taken together, occupancy of CD44 drives leukemic T cells into apoptosis. This is accompanied by PP2A associating with CD44 and PP2A activation, which strongly promotes ERK1/2 dephosphorylation, mitochondrial membrane depolarization and caspase-9 cleavage. [36] [37] [38] 46] . There is strong evidence that leukaemia initiating cells may also require CD44 for niche embedding and that an antibody blockade of CD44 can hamper leukaemia growth such that LSC survival becomes impaired and/or LSCs are driven into differentiation [16, 18, 19, [33] [34] [35] . Thus, anti-CD44 treatment could be considered as a therapeutic option in leukaemia. However, because CD44 is also required during haematopoiesis, it becomes important to elaborate possible differences in CD44 activities in haematopoiesis versus leukaemia growth.
Discussion
CD44 plays an important role in HSC homing and embedding in the bone marrow niche, which is supposed to support HSC survival [5]. CD44 is also important for progenitor T-cell homing into the thymus as well as for thymocyte differentiation via a crosstalk with the thymic stroma
T lymphoma cells are less CD44-dependent than haematopoietic progenitors
Anti-CD44 treatment retards T lymphoma growth, particularly at a subcutaneous site. This corresponds, although far less pronounced, to the effect of anti-CD44 treatment in myeloid leukaemia [18, 19] [3] . As far as the leukaemia strongly expresses a CD44v, the therapeutic application of CD44v-specific antibodies may not attack HSC. A bispecific antibody that recognizes CD44 and an additional leukaemia marker, will also spare HSC and progenitor cells [47] . We plan to control this hypothesis in the murine leukaemia model.
A CD44 antibody blockade promotes death receptor-independent leukemic T cell apoptosis
Independently of these side effects, in the non-reconstituted mouse anti-CD44 treatment retarded lymphoma growth. As a first step towards a therapeutic exploitation, we aimed to clarify the underlying mechanism. In line with several reports [16, [33] [34] [35] , our in vivo findings provided evidence that a blockade of CD44 can drive leukemic T cells into apoptosis.
Though CD44 occupancy has repeatedly been described to drive activated T cells into apoptosis [29] [30] [31] 48] 
